Lv49
770 积分 2026-01-10 加入
Clinical overview of trophoblast surface antigen 2 Antibody-Drug conjugates in Non–Small cell lung cancer
7天前
已完结
Management of adverse events associated with TROP2-targeted antibody-drug conjugates in cancer patients
7天前
已完结
Trop2 immunoPET/CT in clinical practice: facts and challenges
7天前
已完结
TROP2-Targeted Therapeutics in Development to Treat Gastrointestinal Tumors
12天前
已完结
Molecular Advances in Gastrointestinal Pathology
12天前
已关闭
Tiragolumab plus atezolizumab and chemotherapy as first-line treatment for patients with unresectable oesophageal squamous cell carcinoma (SKYSCRAPER-08): a randomised, double-blind, placebo-controlled, phase 3 trial
29天前
已完结
Oncogenic and tumor-suppressive forces converge on a progenitor niche at the benign-to-malignant transition
2个月前
已完结
Intratumoral T reg cell ablation elicits NK cell–mediated control of CD8 T cell–resistant tumors
2个月前
已完结
Precancerous niche remodelling dictates nascent tumour persistence
3个月前
已完结
Alleviated T cell exhaustion and SLC1A3-mediated stroma-remodelling dictate chemoimmunotherapy efficacy in oesophageal squamous cell carcinoma
4个月前
已完结
皖公网安备34019202002308
